Avalo Therapeutics, Inc. — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001534120-26-000016 | Mar 27, 2026 | Mar 23, 2026 |
| S-8 | FORM S-8 | 0001104659-26-032997 | Mar 23, 2026 | — |
| 10-K | 10-K | 0001534120-26-000011 | Mar 23, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001534120-26-000010 | Mar 23, 2026 | — |
| 4 | — | 0001918845-26-000004 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001950047-26-002672 | Mar 16, 2026 | — |
| SCHEDULE 13G | — | 0000315066-26-000651 | Mar 6, 2026 | — |
| 4 | — | 0001677896-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0002047607-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001918845-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0002090172-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001810417-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | — | 0001586785-26-000002 | Mar 2, 2026 | Feb 26, 2026 |
| SCHEDULE 13G | — | 0001104659-26-019185 | Feb 24, 2026 | — |
| SCHEDULE 13G/A | — | 0000947871-26-000187 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001727492-26-000006 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001147 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001346824-26-000035 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-016415 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000921895-26-000454 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-052938 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-012613 | Feb 10, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-012459 | Feb 10, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-009818 | Feb 3, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000048 | Jan 30, 2026 | — |
| SCHEDULE 13G/A | — | 0001315863-26-000095 | Jan 29, 2026 | — |
| EFFECT | — | 9999999995-26-000222 | Jan 20, 2026 | — |
| 8-K | 8-K | 0001534120-26-000003 | Jan 12, 2026 | — |
| S-3 | S-3 | 0001104659-26-002118 | Jan 8, 2026 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001470831-26-000007 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001470831-26-000006 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001470831-25-000412 | Dec 12, 2025 | Dec 10, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001470831-25-000411 | Dec 12, 2025 | Dec 10, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001470831-25-000410 | Dec 12, 2025 | Dec 10, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001470831-25-000409 | Dec 12, 2025 | Dec 10, 2025 |
| 8-K | 8-K | 0001534120-25-000022 | Dec 2, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0002013869-25-000002 | Nov 17, 2025 | Nov 14, 2025 |
| SCHEDULE 13G/A | — | 0001193125-25-283440 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112690 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001231919-25-000484 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-005012 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-003090 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-004971 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-112178 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-004822 | Nov 14, 2025 | — |
| SCHEDULE 13G | — | 0001193125-25-281204 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001999371-25-017697 | Nov 13, 2025 | — |
| S-8 | S-8 | 0001534120-25-000020 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001534120-25-000018 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001534120-25-000017 | Nov 6, 2025 | — |